Requests for authorisation of conferences and meetings
Any Italian or foreign pharmaceutical company which is the owner of medicines with marketing authorisation in Italy (AIC), or which on the basis of an agreement with the respective owner provides for the actual marketing of medicines, and which intends to organise or contribute to the organisation of a congress, conference or meeting on issues related to the use of medicines, must send to the Italian Medicines Agency a communication authorising the proposed educational meetings in order to allow the Agency to verify their strict technical nature, pursuant to Article 124 of Legislative Decree 219/2006.
Starting from 2 April 2024, it is no longer possible to use the InfoCamere portal and all communications relating to conferences and meetings have to be transmitted exclusively via the new version of the online service "Authorisation for Conferences and Meetings NEW".
Information for organisers
In the case of events in which more than one pharmaceutical company participates (conferences, congresses or meetings to which more than one pharmaceutical company contributes), notifications must be sent jointly, through an Organiser.
Starting from 2 April 2024, the pre-application must be entered by the organisers exclusively through the new version "Authorisation for Conferences and Meetings NEW" available on AIFA's online services.
Data entry takes place in three subsequent steps:
- Entry of conference/meeting data
- Entry of participating companies
- Entry single file
Subsequently, the pharmaceutical companies participating in the event complete and submit their requests through the online service “Authorisation for Conferences and Meetings” in accordance with the provisions of Article 124 of Legislative Decree no. 219 of 24 April 2006.
Information for pharmaceutical companies
Events in which only one pharmaceutical company participates must be communicated to AIFA, by the ACC contact person with a digital signature, through the online service "Authorisation for conferences and meetings".
Companies which contribute with other pharmaceutical companies to the same event must complete the applications, already entered by the organisers, through the online service "Authorisation for conferences and meetings" within the 60 days provided for in paragraph 1, article 124, of legislative decree no. 219 of 24 April 2006.
Please note that for each event, the company is required to pay the fee corresponding to the estimated charge according to the Decree of the Minister of Health of 6 December 2016.
For further clarifications and information regarding the procedure and payment of the fees, please contact the competent accounting and budget office at integraconvcong@aifa.gov.it.
For details on how to access and use the online service Authorisation for conferences and meetings please refer to the available manuals.
Malfunctions related to the online service Authorisation for conferences and meetings must be reported to the AIFA IT helpdesk.